×
About 2,905 results

ALLMedicine™ Central Serous Chorioretinopathy Center

Research & Reviews  1,439 results

Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic ce...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899877
Medicine Zhang Z, Bao X et. al.

Feb 20th, 2021 - Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of complications. However, we report a case of chronic central serous choriore...

Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic centr...
https://doi.org/10.1177/1120672121991053
European Journal of Ophthalmology; Manayath G, Verghese S et. al.

Jan 29th, 2021 - To compare the long-term outcomes in chronic central serous chorioretinopathy (cCSC) following half-fluence photodynamic therapy (HF-PDT) and oral eplerenone treatment. This retrospective comparative study included consecutive patients of cCSC tre...

Central serous chorioretinopathy secondary to solar retinopathy: an unusual presentation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845700
BMJ Case Reports; Rathore P, Singh A

Jan 29th, 2021 - Solar retinopathy (SR) results from unprotected solar eclipse viewing and also from gazing at the sun for a long duration. It has been known for a long that direct viewing of the sun causes visual disruption. Usually, there is a disruption of the ...

Macular neovascularization in AMD, CSC and best vitelliform macular dystrophy: quantita...
https://doi.org/10.1038/s41433-021-01396-2 10.1016/S0161-6420(86)33609-1 10.1016/j.ophtha.2019.11.004 10.1167/iovs.18-24624 10.1016/j.ajo.2018.08.001 10.1097/IAE.0000000000002775 10.1167/tvst.9.9.48 10.1056/NEJMra0801537 10.1038/s41598-019-40406-y 10.1097/IAE.0000000000001357 10.1097/IAE.0000000000000804 10.1038/eye.2015.208 10.1016/j.preteyeres.2015.05.003 10.1007/s00417-017-3888-2
Eye (London, England); Arrigo A, Bordato A et. al.

Jan 26th, 2021 - To perform a quantitative optical coherence tomography (OCT) angiography (OCTA) analysis of macular neovascularization (MNV) secondary to age-related macular degeneration (AMD), central serous chorioretinopathy (CSC) and best vitelliform macular d...

Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813357
BMJ Case Reports; Hipolito-Fernandes D, Luís ME et. al.

Jan 19th, 2021 - Subretinal fluid accumulation in a patient with systemic lupus erythematosus (SLE) may represent a diagnostic challenge. We present a case of a 43-year-old man with baseline diagnosis of SLE and hydroxychloroquine-associated maculopathy who report...

see more →

Clinicaltrials.gov  1,455 results

Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic ce...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899877
Medicine Zhang Z, Bao X et. al.

Feb 20th, 2021 - Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of complications. However, we report a case of chronic central serous choriore...

Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic centr...
https://doi.org/10.1177/1120672121991053
European Journal of Ophthalmology; Manayath G, Verghese S et. al.

Jan 29th, 2021 - To compare the long-term outcomes in chronic central serous chorioretinopathy (cCSC) following half-fluence photodynamic therapy (HF-PDT) and oral eplerenone treatment. This retrospective comparative study included consecutive patients of cCSC tre...

Central serous chorioretinopathy secondary to solar retinopathy: an unusual presentation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845700
BMJ Case Reports; Rathore P, Singh A

Jan 29th, 2021 - Solar retinopathy (SR) results from unprotected solar eclipse viewing and also from gazing at the sun for a long duration. It has been known for a long that direct viewing of the sun causes visual disruption. Usually, there is a disruption of the ...

Macular neovascularization in AMD, CSC and best vitelliform macular dystrophy: quantita...
https://doi.org/10.1038/s41433-021-01396-2 10.1016/S0161-6420(86)33609-1 10.1016/j.ophtha.2019.11.004 10.1167/iovs.18-24624 10.1016/j.ajo.2018.08.001 10.1097/IAE.0000000000002775 10.1167/tvst.9.9.48 10.1056/NEJMra0801537 10.1038/s41598-019-40406-y 10.1097/IAE.0000000000001357 10.1097/IAE.0000000000000804 10.1038/eye.2015.208 10.1016/j.preteyeres.2015.05.003 10.1007/s00417-017-3888-2
Eye (London, England); Arrigo A, Bordato A et. al.

Jan 26th, 2021 - To perform a quantitative optical coherence tomography (OCT) angiography (OCTA) analysis of macular neovascularization (MNV) secondary to age-related macular degeneration (AMD), central serous chorioretinopathy (CSC) and best vitelliform macular d...

Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813357
BMJ Case Reports; Hipolito-Fernandes D, Luís ME et. al.

Jan 19th, 2021 - Subretinal fluid accumulation in a patient with systemic lupus erythematosus (SLE) may represent a diagnostic challenge. We present a case of a 43-year-old man with baseline diagnosis of SLE and hydroxychloroquine-associated maculopathy who report...

see more →

News  11 results

Challenges of Treating Irregular Astigmatism: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/70839

Jan 30th, 2018 - One expert discusses the challenges of understanding and treating an irregular astigmatism. Change can be hard. Donna Suter describes how to take it in stride. A recent study discusses how to identify patients at risk for severe chronic central se...

Spironolactone Helpful in Acute Central Serous Chorioretinopathy
https://www.medscape.com/viewarticle/888816

Nov 19th, 2017 - NEW YORK (Reuters Health) - For patients with acute central serous chorioretinopathy (CSC), oral spironolactone is more effective than observation and absorbs subretinal fluid (SRF) faster, a randomized controlled trial from China suggests. Subret...

Central Serous Chorioretinopathy: An Update on Pathogenesis and Treatment
https://www.medscape.com/viewarticle/734339_4

Search strategy We searched the MEDLINE/PubMed database for articles from March 1969 to January 2010 after following MeSH suggestions for articles including the terms: CSC, chorioretinopathies, and central serous retinopathies. The headline used t...

Mefloquine-Associated Dizziness, Diplopia, and Central Serous Chorioretinopathy
https://www.medscape.com/viewarticle/871366

Abstract and Introduction Abstract Background: Many acute and chronic neurological sequelae from the quinoline derivative antimalarial drug mefloquine, including dizziness and effects on the visual system such as diplopia and blurred vision, may b...

High-dose Antioxidants for Central Serous Chorioretinopathy
https://www.medscape.com/viewarticle/769910

Abstract and Introduction Abstract Background To determine the efficacy of high-dose antioxidants in the acute stage of central serous chorioretinopathy (CSC). Methods This was a randomized placebo-controlled study. The patients with acute CSC (on...

see more →